These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 25533006)

  • 1. Simple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insight.
    Laguna JC; Alegret M; Roglans N
    Nutrients; 2014 Dec; 6(12):5933-54. PubMed ID: 25533006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes?: health be damned! Pour on the sugar.
    Bray GA; Popkin BM
    Diabetes Care; 2014 Apr; 37(4):950-6. PubMed ID: 24652725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women.
    Schulze MB; Manson JE; Ludwig DS; Colditz GA; Stampfer MJ; Willett WC; Hu FB
    JAMA; 2004 Aug; 292(8):927-34. PubMed ID: 15328324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugar consumption, metabolic disease and obesity: The state of the controversy.
    Stanhope KL
    Crit Rev Clin Lab Sci; 2016; 53(1):52-67. PubMed ID: 26376619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and behavioural effects of sucrose and fructose/glucose drinks in the rat.
    Sheludiakova A; Rooney K; Boakes RA
    Eur J Nutr; 2012 Jun; 51(4):445-54. PubMed ID: 21800086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sugar-sweetened soft drinks, obesity, and type 2 diabetes.
    Apovian CM
    JAMA; 2004 Aug; 292(8):978-9. PubMed ID: 15328331
    [No Abstract]   [Full Text] [Related]  

  • 8. Sugars, obesity, and cardiovascular disease: results from recent randomized control trials.
    Rippe JM; Angelopoulos TJ
    Eur J Nutr; 2016 Nov; 55(Suppl 2):45-53. PubMed ID: 27418186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fructose and Cardiometabolic Health: What the Evidence From Sugar-Sweetened Beverages Tells Us.
    Malik VS; Hu FB
    J Am Coll Cardiol; 2015 Oct; 66(14):1615-1624. PubMed ID: 26429086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. French Recommendations for Sugar Intake in Adults: A Novel Approach Chosen by ANSES.
    Tappy L; Morio B; Azzout-Marniche D; Champ M; Gerber M; Houdart S; Mas E; Rizkalla S; Slama G; Mariotti F; Margaritis I
    Nutrients; 2018 Jul; 10(8):. PubMed ID: 30060614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are Liquid Sugars Different from Solid Sugar in Their Ability to Cause Metabolic Syndrome?
    Sundborn G; Thornley S; Merriman TR; Lang B; King C; Lanaspa MA; Johnson RJ
    Obesity (Silver Spring); 2019 Jun; 27(6):879-887. PubMed ID: 31054268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calorie-sweetened beverages and fructose: what have we learned 10 years later.
    Bray GA; Popkin BM
    Pediatr Obes; 2013 Aug; 8(4):242-8. PubMed ID: 23625798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence.
    Hu FB; Malik VS
    Physiol Behav; 2010 Apr; 100(1):47-54. PubMed ID: 20138901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary sugar and artificial sweetener intake and chronic kidney disease: a review.
    Karalius VP; Shoham DA
    Adv Chronic Kidney Dis; 2013 Mar; 20(2):157-64. PubMed ID: 23439375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gradual reduction of sugar in soft drinks without substitution as a strategy to reduce overweight, obesity, and type 2 diabetes: a modelling study.
    Ma Y; He FJ; Yin Y; Hashem KM; MacGregor GA
    Lancet Diabetes Endocrinol; 2016 Feb; 4(2):105-14. PubMed ID: 26777597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between Added Sugars Consumption and Chronic Disease Risk Factors: Current Understanding.
    Rippe JM; Angelopoulos TJ
    Nutrients; 2016 Nov; 8(11):. PubMed ID: 27827899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fructose, pregnancy and later life impacts.
    Regnault TR; Gentili S; Sarr O; Toop CR; Sloboda DM
    Clin Exp Pharmacol Physiol; 2013 Nov; 40(11):824-37. PubMed ID: 24033459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.
    Jensen T; Abdelmalek MF; Sullivan S; Nadeau KJ; Green M; Roncal C; Nakagawa T; Kuwabara M; Sato Y; Kang DH; Tolan DR; Sanchez-Lozada LG; Rosen HR; Lanaspa MA; Diehl AM; Johnson RJ
    J Hepatol; 2018 May; 68(5):1063-1075. PubMed ID: 29408694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence and harm of nonalcoholic fatty liver disease].
    Shao YL; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):10-13. PubMed ID: 30685917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugary drinks in the pathogenesis of obesity and cardiovascular diseases.
    Brown CM; Dulloo AG; Montani JP
    Int J Obes (Lond); 2008 Dec; 32 Suppl 6():S28-34. PubMed ID: 19079277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.